home / stock / enlv / enlv short
Short Information | Enlivex Therapeutics Ltd. (NYSE:ENLV)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 24,039 |
Total Actual Volume | 411,950 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,202 |
Average Short Percentage | 4.60% |
Is there a ENLV Short Squeeze or Breakout about to happen?
See the ENLV Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $8.35 | $8.74 | $8.74 | $8.231 | 5,431 | 150 | 2.76% |
02-11-2020 | $8.60 | $8.20 | $8.60 | $8.00 | 8,670 | 600 | 6.92% |
02-10-2020 | $8.08 | $8.26 | $8.54 | $8.08 | 24,912 | 85 | 0.34% |
02-07-2020 | $7.6101 | $7.75 | $7.75 | $7.6101 | 4,351 | 500 | 11.49% |
02-06-2020 | $7.29 | $7.7108 | $7.79 | $7.29 | 9,029 | 165 | 1.83% |
02-05-2020 | $7.46 | $6.88 | $7.8724 | $6.88 | 28,396 | 195 | 0.69% |
01-31-2020 | $8.11 | $7.99 | $8.15 | $7.54 | 3,719 | 30 | 0.81% |
01-29-2020 | $8.63 | $8.30 | $8.6396 | $8.30 | 5,781 | 261 | 4.51% |
01-28-2020 | $8.57 | $8.98 | $8.98 | $8.3114 | 2,070 | 2 | 0.1% |
01-27-2020 | $8.38 | $8.51 | $8.5701 | $8.22 | 15,643 | 500 | 3.2% |
01-24-2020 | $9.70 | $9.0952 | $9.70 | $9.05 | 4,211 | 11 | 0.26% |
01-23-2020 | $9.88 | $9.91 | $9.91 | $9.50 | 3,375 | 304 | 9.01% |
01-22-2020 | $9.35 | $9.81 | $10.00 | $9.35 | 19,497 | 100 | 0.51% |
01-21-2020 | $9.05 | $9.056 | $9.15 | $8.92 | 18,140 | 740 | 4.08% |
01-17-2020 | $8.54 | $8.928 | $8.9552 | $8.54 | 29,088 | 1,200 | 4.13% |
01-16-2020 | $8.92 | $8.54 | $8.92 | $8.54 | 27,969 | 1,400 | 5.01% |
01-14-2020 | $9.85 | $9.60 | $10.07 | $9.12 | 29,718 | 1,293 | 4.35% |
01-13-2020 | $9.50 | $9.45 | $9.60 | $9.02 | 119,599 | 6,638 | 5.55% |
01-10-2020 | $8.50 | $8.40 | $8.65 | $8.40 | 6,177 | 361 | 5.84% |
01-09-2020 | $8.45 | $8.41 | $8.68 | $8.25 | 46,174 | 9,504 | 20.58% |
News, Short Squeeze, Breakout and More Instantly...
Enlivex Therapeutics Ltd. Company Name:
ENLV Stock Symbol:
NYSE Market:
Enlivex Therapeutics Ltd. Website:
First patient dosed with Allocetra TM in thumb osteoarthritis, a degenerative, debilitating and progressive disease that affects millions of people Thumb osteoarthritis currently has no FDA-approved therapy and no effective long-term treatments Ness-Ziona, Israel, June 24, 2024 (GLO...
Ness-Ziona, Israel, June 20, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company” or “Enlivex”), a clinical-stage macrophage reprogramming immunotherapy company, is pleased to invite investors to a webinar on June 25, 2024, at 4:15 p.m...
Key Highlights Enrolled patients with severe knee osteoarthritis who were indicated for knee-replacement surgery received a single local injection of Allocetra TM into the knee as a “last resort” Three-month data readout showed a significant reduction in pain and a f...